The US spends more per capita on healthcare than any other country but ranks poorly on population health metrics (life expectancy, infant mortality). Does this prove that US healthcare is inefficient?
AYes — higher spending with worse outcomes is the definition of inefficiency
BNot necessarily — population health outcomes are determined by many factors beyond healthcare (poverty, gun violence, obesity, substance abuse, social determinants). The US may have an excellent clinical system operating in a population context that produces worse aggregate health. But the comparison does demonstrate that high spending does not guarantee good population health.
CNo — the US has the best healthcare quality in the world
DThe comparison is meaningless because countries define outcomes differently
This is one of the most important distinctions in health economics: the health system is responsible for only a fraction of population health outcomes. Social determinants (income inequality, education, housing, nutrition, safety) may contribute more to life expectancy and infant mortality than healthcare per se. The US has high-quality clinical care for insured patients but also has deep poverty, high homicide rates, opioid deaths, and limited social safety nets — all of which drag down population health metrics. High spending with poor population outcomes reflects both system inefficiency (administrative waste, overpriced services) and non-system factors.
Question 2 Short Answer
The WHO's 2000 World Health Report ranked France #1 and the US #37 in overall health system performance. This ranking was widely cited but also widely criticized. What was the main methodological criticism?
Think about your answer, then reveal below.
Model answer: The main criticism was that the composite ranking combined highly uncertain estimates of different dimensions (health attainment, responsiveness, fairness of financing, efficiency) using largely arbitrary weights, and then ranked 191 countries based on small differences that fell within the confidence intervals of the estimates. Many adjacent rankings were not statistically distinguishable. The ranking also conflated the health system's contribution with non-health-system determinants of health and used controversial methods to estimate 'efficiency' (the gap between actual and predicted health outcomes given spending). The ranking was influential but oversimplified a complex, multidimensional evaluation problem.
The WHO ranking demonstrated the political power and methodological peril of composite indices. It put health system performance on the global policy agenda but also showed that condensing complex systems into a single number inevitably loses information and introduces judgment calls disguised as objectivity. Most subsequent work in this area has moved toward dashboards (reporting multiple indicators separately) rather than single composite scores.
Question 3 True / False
A health system that achieves excellent average outcomes but with large disparities between rich and poor is performing well on effectiveness but poorly on equity.
TTrue
FFalse
Answer: True
Health system performance is inherently multidimensional. A system that provides excellent care to the wealthy while the poor receive little or no care produces good average outcomes (especially if the wealthy majority is large) but fails on equity — a separate and equally important dimension. The WHO framework explicitly includes fairness of financing and equity of health outcomes as performance dimensions, precisely because average measures can mask distributional injustice. Most performance frameworks now report outcomes stratified by income, geography, race/ethnicity, and other dimensions of inequality.